S&P 500$7,609.78
+0.13%
2m
DOW 30$50,687.07
-1.21%
2m
NASDAQ 100$30,571.24
-0.29%
2m
Russell 2000$291.66
+0.93%
2m
Russell 1000$414.78
+0.21%
2m
S&P 400$3,751.11
-0.10%
2m
S&P 600$1,696.37
+0.88%
2m

APYX MEDICAL (APYX)

NASDAQ

$3.91+$0.06 (+1.58%)

Price as of Jun 03, 2026 5:08 PM EDT

$167.3M
Market Cap
137.65%
1-Year Change
Medical Devices
Industry

Annual

Quarterly

	12/31/2025	12/31/2024	12/31/2023	12/31/2022
Income Statement
Total Operating Revenue	52.8M +9.86%	48.1M -8.11%	52.3M +17.61%	44.5M -8.26%
Cost of Revenue	19.8M +5.65%	18.7M +0.82%	18.6M +20.88%	15.4M +3.10%
Gross Profit	33.0M +12.55%	29.4M -13.03%	33.8M +15.89%	29.1M -13.30%
Sales and Marketing Expense	15.8M -16.20%	18.9M -15.05%	22.2M +8.37%	20.5M +10.03%
Research and Development Expense	-3.4M -33.60%	-5.1M +4.87%	-4.8M +6.60%	-4.5M +5.16%
Depreciation and Amortization Expense	655,000 +9.35%	599,000 -13.44%	692,000 -22.25%	890,000 -1.44%
Total Operating Expenses	39.5M -18.08%	48.2M -10.25%	53.7M +1.93%	52.7M +9.67%
Operating Profit	-6.4M -65.79%	-18.8M +9.19%	-17.3M -26.75%	-23.6M +63.08%
Interest Income	1.1M -31.01%	1.6M +74.38%	921,000 +486.62%	157,000 +1,327.27%
Interest Expense	N/A N/A	N/A N/A	-2.5M +16,420.00%	-15,000 +50.00%
Interest Income and Expense and Net	1.1M -31.01%	1.6M +203.15%	-1.6M -1,196.48%	142,000 +14,100.00%
Total Nonoperating Income and Expense	-4.4M -1.64%	-4.5M +10.91%	-4.0M -717.97%	651,000 +275.00%
Income before Taxes	-10.8M -53.51%	-23.3M +9.52%	-21.3M -7.11%	-22.9M +54.60%
Income Taxes	270,000 +7.14%	252,000 +110.36%	-2.4M -762.67%	367,000 -3.42%
Extraordinary Items	N/A N/A	N/A N/A	N/A N/A	N/A N/A
Net Income	-11.2M -52.22%	-23.5M +25.38%	-18.7M -19.28%	-23.2M +52.81%
Net Income from Continuing Operations Applicable to Common	-10.8M -53.51%	-23.3M +9.52%	-21.3M -7.11%	-22.9M +54.60%
Basic EPS and Net Income	-0.27 -59.09%	-0.66 +22.22%	-0.54 -19.40%	-0.67 +52.27%
Diluted EPS and Net Income	-0.27 -59.09%	-0.66 +22.22%	-0.54 -19.40%	-0.67 +52.27%
Basic Weighted Average Shares	41.1M +15.62%	35.5M +2.66%	34.6M +0.31%	34.5M +0.54%
Diluted Weighted Average Shares	41.1M +15.62%	35.5M +2.66%	34.6M +0.31%	34.5M +0.54%
Balance Sheet
Cash and Cash Equivalents	31.7M -0.003%	31.7M -27.29%	43.7M +328.30%	10.2M -66.98%
Short-Term Investments	N/A N/A	N/A N/A	N/A N/A	N/A N/A
Cash and Cash Equivalents and Short-Term Investments	31.7M -0.003%	31.7M -27.29%	43.7M +328.30%	10.2M -66.98%
Total Current Assets	58.5M +3.60%	56.4M -19.79%	70.4M +63.74%	43.0M -29.25%
Accumulated Depreciation	4.3M +7.62%	4.0M +13.26%	3.5M -30.13%	5.0M -5.17%
Property and Plant and Equipment and Net	2.4M +19.33%	2.0M +3.76%	1.9M -71.68%	6.8M +2.83%
Total Long-Term Assets	1.8M +5.29%	1.7M -3.93%	1.7M +42.32%	1.2M +9.64%
Total Assets	66.8M +3.08%	64.8M -18.17%	79.2M +53.05%	51.8M -24.66%
Income Taxes Payable	N/A N/A	N/A N/A	N/A N/A	245,000 -42.76%
Total Short-Term Debt	N/A N/A	N/A N/A	N/A N/A	N/A N/A
Total Current Liabilities	11.7M +9.13%	10.7M -15.85%	12.7M +7.51%	11.8M -10.26%
Total Long-Term Debt	34.8M +2.82%	33.9M +2.13%	33.2M N/A	N/A N/A
Total Long-Term Liabilities	347,000 +33.98%	259,000 +30.81%	198,000 +9.39%	181,000 +9.04%
Total Liabilities	52.0M +2.97%	50.5M -3.46%	52.3M +274.18%	14.0M -4.96%
Retained Earnings	-89.1M +14.39%	-77.9M +43.09%	-54.4M +52.37%	-35.7M +184.72%
Total Stockholders Equity	14.5M +2.32%	14.2M -46.78%	26.7M -28.95%	37.6M -30.02%
Total Shares Outstanding	41.8M +10.56%	37.8M +9.09%	34.6M +0.13%	34.6M +0.55%
Cash Flow
Cash from Operating Activities	-8.0M -55.67%	-18.0M +243.82%	-5.2M -74.12%	-20.3M +94.09%
Capital Expenditures	1.1M +54.29%	722,000 +35.46%	533,000 -47.23%	1.0M +39.70%
Cash from Investing Activities	-1.1M +54.29%	-722,000 -110.72%	6.7M +766.73%	-1.0M +39.70%
Dividends Paid	N/A N/A	N/A N/A	N/A N/A	N/A N/A
Cash from Financing Activities	9.6M +42.03%	6.7M -79.03%	32.2M +14,723.04%	217,000 +804.17%
Financials Ratio
Gross Margin	62.53% +2.45%	61.04% -5.35%	64.49% -1.47%	65.45% -5.50%
Operating Margin	-12.20% -68.86%	-39.18% +18.83%	-32.97% -37.72%	-52.94% +77.76%
Return on Assets	-17.03% -47.72%	-32.57% +14.01%	-28.57% -25.77%	-38.48% +81.13%
Return on Equity	-77.99% -32.01%	-114.70% +97.01%	-58.22% +14.62%	-50.79% +96.56%
Revenue Growth	9.86% +221.51%	-8.11% -146.07%	17.61% +313.24%	-8.26% -111.00%
Current Ratio	5.00 -5.07%	5.26 -4.68%	5.52 +52.30%	3.63 -21.16%
Cash Ratio	2.71 -8.37%	2.96 -13.59%	3.43 +298.37%	0.86 -63.21%
Debt-to-Equity Ratio	N/A N/A	N/A N/A	N/A N/A	N/A N/A
Debt-to-Assets Ratio	N/A N/A	N/A N/A	N/A N/A	N/A N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow